Literature DB >> 29677503

Revolutionizing Precision Oncology through Collaborative Proteogenomics and Data Sharing.

Henry Rodriguez1, Stephen R Pennington2.   

Abstract

The integration of proteomics into precision oncology presents opportunities that may transform the molecular analysis of cancer and accelerate basic and clinical cancer research. This Commentary discusses the importance of international collaboration and data sharing inspired by the Cancer Moonshot to accelerate the progress of multi-omic precision medicine-an approach that addresses the global diversity of people and of cancers. Published by Elsevier Inc.

Entities:  

Mesh：

Year:  2018        PMID： 29677503      PMCID： PMC6002958          DOI： 10.1016/j.cell.2018.04.008

Source DB:  PubMed          Journal:  Cell        ISSN： 0092-8674            Impact factor:   41.582


  15 in total

1.  Recommendations for mass spectrometry data quality metrics for open access data (corollary to the Amsterdam Principles).

Authors:  Christopher R Kinsinger; James Apffel; Mark Baker; Xiaopeng Bian; Christoph H Borchers; Ralph Bradshaw; Mi-Youn Brusniak; Daniel W Chan; Eric W Deutsch; Bruno Domon; Jeff Gorman; Rudolf Grimm; William Hancock; Henning Hermjakob; David Horn; Christie Hunter; Patrik Kolar; Hans-Joachim Kraus; Hanno Langen; Rune Linding; Robert L Moritz; Gilbert S Omenn; Ron Orlando; Akhilesh Pandey; Peipei Ping; Amir Rahbar; Robert Rivers; Sean L Seymour; Richard J Simpson; Douglas Slotta; Richard D Smith; Stephen E Stein; David L Tabb; Danilo Tagle; John R Yates; Henry Rodriguez
Journal:  Mol Cell Proteomics       Date:  2011-11-03       Impact factor: 5.911

Review 2.  Where next for gefitinib in patients with lung cancer?

Authors:  Fiona Blackhall; Malcolm Ranson; Nick Thatcher
Journal:  Lancet Oncol       Date:  2006-06       Impact factor: 41.316

3.  Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma.

Authors:  Terri A Addona; Susan E Abbatiello; Birgit Schilling; Steven J Skates; D R Mani; David M Bunk; Clifford H Spiegelman; Lisa J Zimmerman; Amy-Joan L Ham; Hasmik Keshishian; Steven C Hall; Simon Allen; Ronald K Blackman; Christoph H Borchers; Charles Buck; Helene L Cardasis; Michael P Cusack; Nathan G Dodder; Bradford W Gibson; Jason M Held; Tara Hiltke; Angela Jackson; Eric B Johansen; Christopher R Kinsinger; Jing Li; Mehdi Mesri; Thomas A Neubert; Richard K Niles; Trenton C Pulsipher; David Ransohoff; Henry Rodriguez; Paul A Rudnick; Derek Smith; David L Tabb; Tony J Tegeler; Asokan M Variyath; Lorenzo J Vega-Montoto; Asa Wahlander; Sofia Waldemarson; Mu Wang; Jeffrey R Whiteaker; Lei Zhao; N Leigh Anderson; Susan J Fisher; Daniel C Liebler; Amanda G Paulovich; Fred E Regnier; Paul Tempst; Steven A Carr
Journal:  Nat Biotechnol       Date:  2009-06-28       Impact factor: 54.908

4.  Biological rationale for HER2/neu (c-erbB2) as a target for monoclonal antibody therapy.

Authors:  M Pegram; D Slamon
Journal:  Semin Oncol       Date:  2000-10       Impact factor: 4.929

5.  Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia.

Authors:  Brian J Druker; François Guilhot; Stephen G O'Brien; Insa Gathmann; Hagop Kantarjian; Norbert Gattermann; Michael W N Deininger; Richard T Silver; John M Goldman; Richard M Stone; Francisco Cervantes; Andreas Hochhaus; Bayard L Powell; Janice L Gabrilove; Philippe Rousselot; Josy Reiffers; Jan J Cornelissen; Timothy Hughes; Hermine Agis; Thomas Fischer; Gregor Verhoef; John Shepherd; Giuseppe Saglio; Alois Gratwohl; Johan L Nielsen; Jerald P Radich; Bengt Simonsson; Kerry Taylor; Michele Baccarani; Charlene So; Laurie Letvak; Richard A Larson
Journal:  N Engl J Med       Date:  2006-12-07       Impact factor: 91.245

6.  Repeatability and reproducibility in proteomic identifications by liquid chromatography-tandem mass spectrometry.

Authors:  David L Tabb; Lorenzo Vega-Montoto; Paul A Rudnick; Asokan Mulayath Variyath; Amy-Joan L Ham; David M Bunk; Lisa E Kilpatrick; Dean D Billheimer; Ronald K Blackman; Helene L Cardasis; Steven A Carr; Karl R Clauser; Jacob D Jaffe; Kevin A Kowalski; Thomas A Neubert; Fred E Regnier; Birgit Schilling; Tony J Tegeler; Mu Wang; Pei Wang; Jeffrey R Whiteaker; Lisa J Zimmerman; Susan J Fisher; Bradford W Gibson; Christopher R Kinsinger; Mehdi Mesri; Henry Rodriguez; Stephen E Stein; Paul Tempst; Amanda G Paulovich; Daniel C Liebler; Cliff Spiegelman
Journal:  J Proteome Res       Date:  2010-02-05       Impact factor: 4.466

7.  Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer.

Authors:  Hui Zhang; Tao Liu; Zhen Zhang; Samuel H Payne; Bai Zhang; Jason E McDermott; Jian-Ying Zhou; Vladislav A Petyuk; Li Chen; Debjit Ray; Shisheng Sun; Feng Yang; Lijun Chen; Jing Wang; Punit Shah; Seong Won Cha; Paul Aiyetan; Sunghee Woo; Yuan Tian; Marina A Gritsenko; Therese R Clauss; Caitlin Choi; Matthew E Monroe; Stefani Thomas; Song Nie; Chaochao Wu; Ronald J Moore; Kun-Hsing Yu; David L Tabb; David Fenyö; Vineet Bafna; Yue Wang; Henry Rodriguez; Emily S Boja; Tara Hiltke; Robert C Rivers; Lori Sokoll; Heng Zhu; Ie-Ming Shih; Leslie Cope; Akhilesh Pandey; Bing Zhang; Michael P Snyder; Douglas A Levine; Richard D Smith; Daniel W Chan; Karin D Rodland
Journal:  Cell       Date:  2016-06-29       Impact factor: 41.582

8.  Targeted peptide measurements in biology and medicine: best practices for mass spectrometry-based assay development using a fit-for-purpose approach.

Authors:  Steven A Carr; Susan E Abbatiello; Bradley L Ackermann; Christoph Borchers; Bruno Domon; Eric W Deutsch; Russell P Grant; Andrew N Hoofnagle; Ruth Hüttenhain; John M Koomen; Daniel C Liebler; Tao Liu; Brendan MacLean; D R Mani; Elizabeth Mansfield; Hendrik Neubert; Amanda G Paulovich; Lukas Reiter; Olga Vitek; Ruedi Aebersold; Leigh Anderson; Robert Bethem; Josip Blonder; Emily Boja; Julianne Botelho; Michael Boyne; Ralph A Bradshaw; Alma L Burlingame; Daniel Chan; Hasmik Keshishian; Eric Kuhn; Christopher Kinsinger; Jerry S H Lee; Sang-Won Lee; Robert Moritz; Juan Oses-Prieto; Nader Rifai; James Ritchie; Henry Rodriguez; Pothur R Srinivas; R Reid Townsend; Jennifer Van Eyk; Gordon Whiteley; Arun Wiita; Susan Weintraub
Journal:  Mol Cell Proteomics       Date:  2014-01-17       Impact factor: 5.911

9.  Demonstrating the feasibility of large-scale development of standardized assays to quantify human proteins.

Authors:  Jacob J Kennedy; Susan E Abbatiello; Kyunggon Kim; Ping Yan; Jeffrey R Whiteaker; Chenwei Lin; Jun Seok Kim; Yuzheng Zhang; Xianlong Wang; Richard G Ivey; Lei Zhao; Hophil Min; Youngju Lee; Myeong-Hee Yu; Eun Gyeong Yang; Cheolju Lee; Pei Wang; Henry Rodriguez; Youngsoo Kim; Steven A Carr; Amanda G Paulovich
Journal:  Nat Methods       Date:  2013-12-08       Impact factor: 28.547

10.  Proteogenomics connects somatic mutations to signalling in breast cancer.

Authors:  Philipp Mertins; D R Mani; Kelly V Ruggles; Michael A Gillette; Karl R Clauser; Pei Wang; Xianlong Wang; Jana W Qiao; Song Cao; Francesca Petralia; Emily Kawaler; Filip Mundt; Karsten Krug; Zhidong Tu; Jonathan T Lei; Michael L Gatza; Matthew Wilkerson; Charles M Perou; Venkata Yellapantula; Kuan-lin Huang; Chenwei Lin; Michael D McLellan; Ping Yan; Sherri R Davies; R Reid Townsend; Steven J Skates; Jing Wang; Bing Zhang; Christopher R Kinsinger; Mehdi Mesri; Henry Rodriguez; Li Ding; Amanda G Paulovich; David Fenyö; Matthew J Ellis; Steven A Carr
Journal:  Nature       Date:  2016-05-25       Impact factor: 49.962
View more
  17 in total

1.  Novel MicroRNA-Based Risk Score Identified by Integrated Analyses to Predict Metastasis and Poor Prognosis in Breast Cancer.

Authors:  Tstutomu Kawaguchi; Li Yan; Qianya Qi; Xuan Peng; Stephen B Edge; Jessica Young; Song Yao; Song Liu; Eigo Otsuji; Kazuaki Takabe
Journal:  Ann Surg Oncol       Date:  2018-10-11       Impact factor: 5.344

2.  Interdisciplinary team science to understand and intercept rare cancers.

Authors:  Stefan Fröhling
Journal:  Mol Cell Oncol       Date:  2021-11-23

3.  A Targeted Proteomics Approach for Screening Serum Biomarkers Observed in the Early Stage of Type I Endometrial Cancer.

Authors:  Blendi Ura; Valeria Capaci; Michelangelo Aloisio; Giovanni Di Lorenzo; Federico Romano; Giuseppe Ricci; Lorenzo Monasta
Journal:  Biomedicines       Date:  2022-08-02

Review 4.  Mass spectrometry-based targeted proteomics for analysis of protein mutations.

Authors:  Tai-Tu Lin; Tong Zhang; Reta B Kitata; Tao Liu; Richard D Smith; Wei-Jun Qian; Tujin Shi
Journal:  Mass Spectrom Rev       Date:  2021-10-31       Impact factor: 9.011

5.  Proteome-based pathology: the next frontier in precision medicine.

Authors:  Michael H Roehrl; Victor B Roehrl; Julia Y Wang
Journal:  Expert Rev Precis Med Drug Dev       Date:  2021

6.  Lanthanide-Loaded Nanoparticles as Potential Fluorescent and Mass Probes for High-Content Protein Analysis.

Authors:  Worapol Ngamcherdtrakul; Thanapon Sangvanich; Shaun Goodyear; Moataz Reda; Shenda Gu; David J Castro; Primana Punnakitikashem; Wassana Yantasee
Journal:  Bioengineering (Basel)       Date:  2019-03-15

Review 7.  Exploiting Interdata Relationships in Next-generation Proteomics Analysis.

Authors:  Burcu Vitrinel; Hiromi W L Koh; Funda Mujgan Kar; Shuvadeep Maity; Justin Rendleman; Hyungwon Choi; Christine Vogel
Journal:  Mol Cell Proteomics       Date:  2019-05-24       Impact factor: 5.911

8.  Right data for right patient-a precisionFDA NCI-CPTAC Multi-omics Mislabeling Challenge.

Authors:  Emily Boja; Živana Težak; Bing Zhang; Pei Wang; Elaine Johanson; Denise Hinton; Henry Rodriguez
Journal:  Nat Med       Date:  2018-09       Impact factor: 53.440

Review 9.  The next horizon in precision oncology: Proteogenomics to inform cancer diagnosis and treatment.

Authors:  Henry Rodriguez; Jean Claude Zenklusen; Louis M Staudt; James H Doroshow; Douglas R Lowy
Journal:  Cell       Date:  2021-04-01       Impact factor: 41.582

10.  Proteogenomic analysis of melanoma brain metastases from distinct anatomical sites identifies pathways of metastatic progression.

Authors:  Erin M Taylor; Stephanie D Byrum; Jacob L Edmondson; Christopher P Wardell; Brittany G Griffin; Sara C Shalin; Murat Gokden; Issam Makhoul; Alan J Tackett; Analiz Rodriguez
Journal:  Acta Neuropathol Commun       Date:  2020-09-05       Impact factor: 7.801
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.